H ost defense to mouse CMV (MCMV; a b-herpesvirus) involves multiple cell types of both the innate and adaptive immune systems (1) . Two innate-like lymphocyte populations, NK cells and NKT cells, are major producers of IFN-g early during MCMV infection (2, 3) . NKT cells are a T lymphocyte subset that is characterized by expression of an invariant TCR a-chain, formed by a Va14 to Ja18 rearrangement in mice. When paired with several b-chains, prominently Vb8.2, this a-chain imparts specificity for glycolipids presented by CD1d, a class I-like Ag-presenting molecule. These cells are commonly referred to as type I or invariant NK T (iNKT) cells. The iNKT cell TCR is capable of recognizing several types of glycolipid Ags derived from microbial, environmental, or endogenous sources (4) (5) (6) (7) . Although NK cells are truly innate lymphocytes, we refer to iNKT cells as innate-like cells, because although they are bona fide T cells that mature in the thymus, they carry out very rapid effector responses.
In addition to TCR/CD1d-dependent activation of iNKT cells, Ag-independent activation of these lymphocytes also can occur: for example, in response to viruses or TLR ligands, which typically results in their exclusive production of IFN-g, whereas TCR stimulation results in IL-4, as well as other cytokines. This "indirect" iNKT cell activation was shown to involve dendritic cells (DCs), and potentially other APCs, which produce cytokines in response to TLR triggering (3, (8) (9) (10) . To this point, the key cytokines promoting iNKT cell activation in these experimental systems have been IL-12, IL-18, and IFN-I, with IL-12 playing a dominant role. This also holds true in the case of MCMV infection, with IL-12 2/2 mice being severely compromised for iNKT activation, whereas IL-18-or IFN-I signaling-deficient mice show only very modest reductions (3, 10) . In these cases, in which no foreign lipid Ag is present to contribute to iNKT activation, IL-12 may synergize with TCR recognition of self-Ags presented by CD1d (11) . However, iNKT cells are activated normally in MCMV-infected mice where CD1d expression is lacking or blocked (3, 10) , providing evidence for a purely cytokine-driven activation process.
Despite being distinct cell lineages, NK and iNKT cells are similar in some respects, including the shared expression of NK cell receptors, dependence upon IL-15 signaling, overlapping tissue localization, and the ability to rapidly release copious amounts of cytokines, particularly IFN-g, following infection. Consistent with these shared properties, both cell types have been implicated in the immune response to viral, bacterial, and parasitic infections. Further linkage comes from evidence showing that iNKT cells promote the secondary activation of NK cells through iNKT cell expression of CD40L, which mediates the activation of APCs (9, 12) . Taken together, these data suggest that iNKT and NK cells could play similar, and potentially redundant, roles in innate defense to infection.
The critical role of NK cell-mediated protection during MCMV infection has been studied extensively (13, 14) . In C57BL/6 (B6) mice, recognition of the MCMV m157 protein by NK cells expressing the Ly49H-activating receptor results in enhanced control of early replication (15) . In turn, the lack of an Ly49H homolog in BALB/c mice results in significantly enhanced levels of early MCMV replication (16) . At very early times of MCMV infection (8-12 h ), a burst of IFN-I synthesis emanating from infected stromal cells promotes the activation of NK cell cytolytic activity (1, 17, 18) . By ∼36 h, MCMV has completed its first replication cycle, and it subsequently triggers DC populations to produce IL-12 and IL-18, in addition to a second wave of IFN-I (19, 20) . Although iNKT cells show markers of activation at 12 h (3), it is only at ∼36 h when a large proportion of NK and iNKT cells produce IFN-g (2, 3, 10) . Notably, plasmacytoid DCs are the primary source of innate cytokines at 36 h, leading to NK and iNKT cell IFN-g production through TLR9-dependent recognition of MCMV (3, 21, 22) .
In this study, we explored the regulation of NK and iNKT cells by APC-produced cytokines and determined whether they have distinct roles in antiviral control. We find that iNKT and NK cells have different cytokine-mediated activation requirements, and they contribute to MCMV innate defense in a nonredundant fashion.
Materials and Methods

Ethics statement
This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. ), and BALB/c mice were purchased from The Jackson Laboratory. CD1d1 2/2 mice were a kind gift from Dr. L. Van Kaer (Vanderbilt University, Nashville TN). Tlr9 cpg1 mice were a kind gift from Dr. B. Beutler (University of Texas Southwestern Medical Center, Dallas, TX). BALB/c Ja18 2/2 mice were a kind gift from Dr. M. Taniguchi (Riken Research Center for Allergy and Immunology, Yokohama, Japan) and were maintained as Ja18 +/2 heterozygotes. Ja18 +/+ and Ja18 2/2 littermates were used for MCMV infection experiments. 4get mice on the B6 background were a kind gift from Dr. R. Locksley (University of California San Francisco, San Francisco CA). All mice were housed in specific pathogenfree conditions.
Reagents and Abs
mAbs to the following mouse Ags were purchased from BD Biosciences, as purified or conjugates to FITC, Alexa Fluor 488, PE, PerCP-cyanin (Cy)5.5, PE-Cy7, allophycocyanin, or Becton Dickinson Horizon V450 or V500: TCR-b, CD11b, CD8a, NK1.1, CD11c, CD44, CD25, CD69, CD4, CD212 (IL-12Rb1), IL-4, TNF, DX5, and IFN-g. A mAb to CD218a (IL-18Ra) conjugated to Alexa Fluor 647 was purchased from BioLegend. PEconjugated aGalCer-CD1d tetramers were generated in our laboratory, as previously described (9) , and used to stain cell suspensions. Recombinant mouse IL-12 and IL-18 were purchased from R&D Systems. IFN-b was purchased from PBL Interferon Source.
No-touch iNKT cell isolation
Spleens from 4get mice were isolated at 8-10 wk of age and dissociated into single-cell suspensions, and RBCs were lysed using red cell lysing buffer (Sigma-Aldrich), washed, filtered, and counted. Single-cell preparations were stained with a custom mixture of biotin-labeled Abs containing anti-CD8a, CD11b, CD19, CD24, CD62L, B220, F4/80, Gr-1, and Ter119. Labeled cells were loaded onto a RoboSep cell separation system using a custom enrichment reagent kit and protocol, according to the manufacturer's instructions (STEMCELL Technologies, Vancouver, BC, Canada). iNKT cells were enriched up to 20%, and eGFP bright cells were sorted using a FACSAria II (BD Biosciences). Sorted cells were 99% GFP + , with the purity of the cells collected being typically .91% iNKT cells, as assessed using CD1d tetramers loaded with aGalCer (Supplemental Fig. 1 ).
Cell preparation and cell culture
All cell preparations were conducted using complete IMDM (Invitrogen Life Technologies) supplemented with 10% FBS, penicillin-streptomycinglutamine, and 2-ME. DCs were prepared using two systems. For GM-CSF-derived DCs, bone marrow was harvested and cultured in 10-cm bacterial dishes in complete IMDM supplemented with 20 ng/ml recombinant mouse GM-CSF (provided by Kyowa Hakko Kirin). On day 4, half of the media was replaced with complete IMDM containing GM-CSF (20 ng/ml). GM-CSF-derived bone marrow-derived DCs (BMDCs) were harvested on day 7. For Flt3 ligand (Flt3L)-derived DCs, bone marrow was harvested and cultured with 100 ng/ml recombinant human Flt3L (Amgen) for 8 d in T75 flasks at a concentration of 45 
Viral infections
Salivary gland stocks of MCMV Smith strain were prepared essentially as described (24) . BALB/c mice were infected with 1 3 10 4 PFU virus in 200 ml PBS via i.p. injection. Four days postinfection, mice were killed by CO 2 asphyxiation, and organs were harvested and immediately snap-frozen in liquid nitrogen. To determine viral titers, organs were weighed and homogenized, and serial dilutions of homogenates were added to monolayers of NIH-3T3 fibroblasts plated in 24-well plates. Plates were spun at 524 3 g for 10 min prior to incubation at 37˚C, which increased the sensitivity of the plaque assays ∼6-10 fold. Cells were fixed with formalin, and plaques were visualized with 0.1% crystal violet and quantified.
Cell depletion
Ja18
+/+ BALB/c and Ja18 2/2 BALB/c mice were depleted of NK cells by injecting 50 ml anti-asialo GM1 rabbit polyclonal Ab (Wako) on day 21 of MCMV infection. NK cell depletion was verified in individual mice by flow cytometry after bleeding and just prior to infection, using a DX5-specific mAb; nonspecific cellular depletion was not observed. Additionally, control mice were Ab depleted of CD8 + T cells (clone 2.43). Depletion was verified by flow cytometric staining with anti-CD8 clone 53-6.7 after bleeding and just prior to infection.
Real-time PCR analysis
Total RNA was isolated from sorted splenic iNKT cells and NK cells using an RNeasy Plus kit (QIAGEN). After DNase I treatment (Ambion), RNA was reverse transcribed using an iScript cDNA synthesis kit (Bio-Rad). Real-time PCR was performed using SYBR Green (Bio-Rad) on a LightCycler 480 Real-Time PCR System with PCR primer pairs for il-12rb1, il-12rb2, il-18r1, il-18rab, ifnar1, and ifnar2 from SABiosciences RT CD25-FITC. All Abs and isotype controls, with the exception of antiTCRb-allophycocyanin-AF750 (eBioscience), were purchased from BD Biosciences. Cells were fixed and permeabilized using Cytofix/Cytoperm buffer and stained for intracellular IFN-g with PE-labeled clone XMG1.2. The data were collected on a LSR II flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star).
Statistics
Differences between groups were evaluated using appropriate statistical tests, as recommended by the La Jolla Institute Bioinformatics Core Facility. Results are expressed as mean 6 SD, except where indicated. The p values , 0.05 were considered significant.
Results
Infected DC subtypes differ in their activation of iNKT cells
We demonstrated previously in cocultures that MCMV infection of Flt3L-expanded BMDCs promoted purified iNKT cells to secrete IFN-g, but not other cytokines, such as the IL-4 that these cells secrete when activated with glycolipid Ags. This did not occur when DCs from IL-12 p40-deficient mice were infected. Together with other studies indicating that IL-12 participates in the activation of iNKT cells (9, 23, 25, 26) , these data strongly implicated the action of IL-12, rather than IL-23, in promoting iNKT cell effector function.
To test whether other DC types can activate iNKT cells upon MCMV infection, DCs derived from GM-CSF-treated bone marrow cultures also were analyzed. GM-CSF or Flt3L-expanded BMDCs were infected with MCMV, treated with CpG ODN, because the activation of IL-12 secretion was shown to be TLR9 dependent, or mock treated prior to the addition of purified iNKT cells or NK cells, and IFN-g production in the culture supernatants was measured ∼48 h later. To assess whether GM-CSF-derived BMDCs activated iNKT cells in a CD1d-dependent manner, Cd1d1
2/2
BMDCs also were tested. In addition, GM-CSF-and Flt3L-derived BMDCs generated from Tlr9 cpg/cpg mice were included as negative controls. For Flt3L-expanded BMDCs, MCMV infection and CpG ODN treatment resulted in the production of IFN-g by both iNKT cells and NK cells (Fig. 1A, 1C ). This activation by MCMV and CpG ODN was independent of CD1d expression but required TLR9 (Supplemental Fig. 2 ), as expected, based on our previous observations (3). CpG ODN treatment of GM-CSF-derived BMDCs also resulted in TLR9-dependent IFNg production by iNKT and NK cells and, again, was independent of CD1d ( Fig. 1B, Supplemental Fig. 2 ). However, when GM-CSF-derived BMDCs were infected with MCMV, NK cells were induced to secrete IFN-g, whereas iNKT cells were unresponsive (Fig. 1D ).
Cell contact is not required for iNKT cell activation by MCMV-infected DCs
MCMV has developed numerous mechanisms to avoid detection by the immune system (1). We (27) previously observed that MCMVinfected GM-CSF-derived BMDCs potently inhibit T cell proliferation through viral modulation of cosignaling pathways, raising the possibility that iNKT cell activation may be similarly suppressed by MCMV. To test this, or any other mechanism dependent on cell contact, supernatants from MCMV-infected Flt3L-or GM-CSF-derived BMDCs were evaluated for their ability to activate iNKT cells. Supernatants from Flt3L-expanded BMDCs activated both NK cells and iNKT cells, indicating that cell contact was not required for the induction of IFN-g synthesis by these innate lymphocytes. In contrast, the supernatant from GM-CSFderived BMDCs activated NK cells but not iNKT cells ( Fig. 2A) . To assess whether a soluble factor released from MCMV-infected GM-CSF-derived BMDCs was inhibiting iNKT cell activation, Flt3L-and GM-CSF-expanded BMDC-derived supernatants were mixed prior to iNKT cell addition. Even at a 10:1 (GM-CSF/ Flt3L) ratio of BMDC supernatants, iNKT cells were activated, demonstrating the absence of a potent inhibitor and, therefore, strongly suggesting that an activating factor was absent in the supernatants derived from MCMV-infected GM-CSF-derived BMDCs (Fig. 2B ).
Infected DC subtypes produce different cytokines
Our results indicated that a secreted factor(s) required for activation of iNKT cells was absent in supernatants from GM-CSF-derived BMDCs infected with MCMV. Our previous work (3, 9) , and that of other investigators (10), indicated that IL-12, IL-18, and IFN-I can all contribute to the activation of iNKT cells, suggesting that the absence of one or more of these factors could be responsible. To address this, Flt3L-and GM-CSF-derived BMDCs were treated with CpG ODN and/or infected with MCMV prior to isolation of supernatants for analysis of IL-12p70, IL-18, and IFN-a by ELISA. Following stimulation with CpG ODN, both Flt3L-and GM-CSF-derived DCs produced approximately similar amounts of these cytokines (Fig. 3A) . However, when GM-CSFderived BMDCs were infected with MCMV, virtually no IL-12 was produced. In contrast, IFN-a production was similar for the two infected DC types, and the amount of IL-18 was significantly higher from infected GM-CSF-derived DCs compared with Flt3L-derived DCs (Fig. 3B) . Importantly, use of an MCMV-GFP virus indicated that the infection efficiency of these two BMDC cultures was similar (data not shown), a fact also reflected by the high-level production of IL-18 and IFN-a by both BMDC types. In summary, although GM-CSF-derived DCs have the capacity to produce IL-12 upon TLR9 activation with CpG ODN, they produced virtually none when exposed to MCMV, despite producing both IFN-I and IL-18 at high levels in response to viral infection.
iNKT cells and NK cells differ in their sensitivity to cytokines
The data obtained from MCMV infection of the two DC subtypes suggested that iNKT cells are more dependent on IL-12 for their activation, whereas, for NK cells, IL-12 may not be essential if other cytokines from innate immune cells are present. To test this, IFN-g production by purified NK and iNKT cell populations was measured after treatment with various amounts of recombinant cytokines in the absence of DCs. When the concentrations of IL-12 or IL-18 were limiting (,10 pg/ml), these two cytokines functioned synergistically to activate both iNKT cells and NK cells to produce IFN-g. For example, when iNKT cells and NK cells were cultured with 10 pg/ml of IL-12, both cell types produced large, and roughly equivalent, amounts of IFN-g across a wide range of IL-18 concentrations (Fig. 4A) . These data suggest that this dose of IL-12, with IL-18 at or below the detection limit of the ELISA assay, induced a maximal response of both iNKT and NK cells. In contrast, fixing the IL-18 at 10 pg/ml and titrating in very limiting amounts of IL-12 (∼0.1-10 pg/ml) revealed that iNKT cells were even more sensitive than NK cells to synergistic activation by combinations of these two cytokines (Fig. 4D) .
When a dose titration of IFN-b was performed in the presence of 10 pg/ml IL-12, similar to what was done for IL-18, an increase in IFN-g production by both NK cells and iNKT cells again was observed. However, under these circumstances, NK cells were more sensitive to the synergistic effects of IFN-b and IL-12 than were iNKT cells (Fig. 4B) . IFN-b alone could not induce IFN-g secretion from iNKT cells, regardless of the dose used, whereas it could promote NK cells to secrete IFN-g when added at higher levels (Fig. 4E, right panel) . Surprisingly, a similar observation was made with IL-18 and IL-12 (Fig. 4E) . Neither of these cytokines alone, even at 1 ng/ml, could activate purified iNKT cells to secrete significant levels of IFN-g. In contrast, NK cells activated by IL-18 or IL-12 alone produced high levels of IFN-g, even at doses as low as 100 and 10 pg/ml, respectively (Fig. 4E) . To attempt to exclude a potential contribution of anti-NK1.1 mAb treatment on "priming" NK cell activation during the purification process, several of these experiments were repeated using DX5 + CD3 2 cells isolated from spleens; similar results were ob- tained (data not shown). Additionally, NK and iNKT cells were purified by cell sorting from BALB/c mice using identical Ab staining panels except TCR-b expression was used to identify iNKT cells. As we observed for C57BL/6 mice, BALB/c NK cells produced IFN-g when single innate cell-derived cytokines were added to cultures, whereas iNKT cells remained unresponsive, even at high doses of either IL-12 or IL-18 alone (data not shown). We also determined whether iNKT cells secrete IFN-g in response to IFN-b and IL-18. Purified iNKT and NK cells were cultured with 10 pg/ml of IL-18, a dose that synergizes with IL-12 to induce their robust activation (Fig. 4D) , together with various amounts of IFN-b. Interestingly, iNKT cells were not activated in response to the combination of IL-18 and IFN-b, whereas NK cells were markedly stimulated (Fig. 4C) . IFN-g secretion by NK and iNKT cells has been associated with the ability of IL-12 to induce STAT4 activation (26, 28) . It was demonstrated previously that NK cells express a high basal level of STAT4 bound to the IFN-I receptor, and, upon exposure to IFN-I, STAT4 is displaced, leading to IFN-g secretion (28) . In agreement with these findings, when NK cells were exposed to high doses of IFN-b, IL-12, or IL-18, STAT4 phosphorylation was detectable within 1 h (Supplemental Fig. 3A) . Meanwhile, STAT4 phosphorylation in iNKT cells was also detectable at high doses of IL-12 (1 ng/ml), giving a bimodal pattern seen in an earlier study (26) . However, this was absent at lower IL-12 concentrations (10 pg/ml), which still robustly activated STAT4 phosphorylation in NK cells, and no STAT4 phosphorylation was observed in iNKT cells cultured with high doses of IL-18 or IFN-b alone (Supplemental Fig. 3B ). However, STAT4 phosphorylation was detectable in iNKT cells at low IL-12 concentrations when combined with IL-18 or IFN-b. Consequently, the pattern of STAT4 phosphorylation in these two cell types reflects their requirements for the induction of IFN-g synthesis. Taken together, these results indicate that iNKT cells and NK cells have different cytokine requirements to activate their production of IFN-g. These results also explain the inability of MCMV-infected GM-CSF-derived BMDCs to activate iNKT cells, despite high levels of virus-induced IFN-b and IL-18 production, because IL-12 production was absent.
Differential sensitivity of NK and iNKT cells to IL-12 in vivo
The amounts of IL-12 and IL-18 induced at ∼36 h after MCMV infection in the sera are in the ng/ml range (29), far above the limiting amounts used to stimulate purified iNKT and NK cells in our in vitro experiments shown in Fig. 4. IFN-b also reaches high levels in the serum at 36 h, but it also exhibits a much earlier peak at 6-8 h in response to MCMV infection of splenic stromal cells (17) . Because purified NK cells produced IFN-g in response to treatment with any one of the single cytokines at ng/ml doses (Fig. 4E) , we postulated that in mice genetically deficient for only one of the cytokines, compared with iNKT cells, the NK cells might show enhanced activation upon MCMV infection in vivo. Consistent with previous results (3, 10), iNKT cell IFN-g synthesis in MCMV-infected mice was strictly dependent on IL-12 when measured by intracellular cytokine staining on cells analyzed directly ex vivo. Although the NK cell response was decreased in the absence of IL-12, these cells still produced measurable levels of IFN-g in the spleen following MCMV infection (Fig. 5) . In contrast, spleen NK cells were unable to produce IFN-g in the absence of IL-18, whereas iNKT cell IFN-g synthesis was not diminished (Fig. 5) . Therefore, the cytokine requirements for the activation of NK cells to secrete IFN-g in vivo may be more stringent than when these cells are purified and cultured with cytokine. Interestingly, NK cells isolated from the livers of infected mice retained the ability to secrete IFN-g in the absence of IL-18, in agreement with previous studies (29), although the response was reduced compared with wild-type (WT) controls (data not shown).
Expression of cytokine receptors by NK and iNKT cells
One possible explanation for the differing sensitivity of NK cells and iNKT cells to combinations of IL-12, IL-18, and IFN-I could be varying levels of cytokine receptor expression. Quantitative PCR analysis of cytokine receptor mRNA levels, as well as protein expression for those receptors where Abs are available, was performed in these two cell populations. Compared with NK cells, both Il12rb1 and Il12rb2 expression levels were higher in freshly purified iNKT cells (∼2-and 3-fold, respectively) (Fig. 6A) , whereas Il18rb1 and Il18rap expression was ∼3-fold lower (Fig.  6B) . Expression of ifnar1 was ∼2-fold higher in NK cells compared with iNKT cells, although the two cell populations expressed similar levels of ifnar2 (Fig. 6C) . To verify whether the increase in mRNA expression correlated with protein, IL-12Rb2 and IL18Ra expression were analyzed by flow cytometry on iNKT and NK cells (Fig. 6D) . Although IL-12Rb2 was readily detectable on tetramer 2 
/CD3
2 NK cells, the highest level of expression was on tetramer + /CD3 + iNKT cells. IL-12Rb1 receptor expression was not detectable on MHC class I-reactive CD8 + ab or gd T cells. Expression of the IL-18Ra-chain was detectable on NK cells, but this was not the case for iNKT cells, conventional ab T cells, or gd T cells in the spleen (Fig. 6D) (26, 30) . Analysis of IL-12R and IL-18R chain expression in iNKT and NK cells isolated from BALB/c mice revealed identical results to those seen in C57BL/6 mice, suggesting that the differential sensitivity of these two cell populations to these innate cytokines may be a general characteristic (data not shown). These trends in the amounts of cytokine receptor expression are consistent with the increased sensitivity of iNKT cells to IL-12 in the presence of IL-18, as well as with the enhanced ability of NK cells to respond to IL-18 + IFN-I. However, the results do not exclude the contribution of additional factors to the differential cytokine sensitivity of the two lymphocyte populations.
iNKT cells contribute to antiviral innate defense
Previous reports (10, 31) indicated that mice genetically deficient for iNKT cells (Ja18 2/2 ) can control MCMV replication normally. However, this has only been examined in B6 mice, which have very robust NK cell-mediated MCMV defenses due to expression of the Ly49H-activating receptor that interacts with the viral m157 protein (32, 33) . In contrast, NK cell-mediated defense against MCMV in BALB/c mice differs significantly from that in B6 mice as the result of a different expression pattern of activating and inhibitory Ly49 family receptors (34) , including a lack of Ly49H. Such differences, including the lack of LY49H, also pertain to many other inbred strains and WT mice, as well (35) . Consequently, we tested whether iNKT cells contribute to MCMV innate defense in BALB/c mice lacking Ly49H by analyzing viral replication in the spleen and liver of Ja18 2/2 mice and WT littermate controls. We found that Ja18 2/2 mice had ∼3-5-fold higher levels of MCMV replication in both of these organs, indicating that iNKT cells play a role in the early control of MCMV replication in some mouse strains (Fig. 7A, 7B ). In separate experiments, we compared MCMV replication in Ja18 2/2 BALB/c mice that were depleted of NK cells using anti-asialo GM1 antisera. Depleting NK cells in mice that lack iNKT cells resulted in a further enhancement of viral replication, which was more dramatic in the liver than the spleen (Fig. 7C, 7D ). Because antiasialo GM1 antisera can potentially deplete activated CD8 + T cells, we verified that MCMV replication was unaltered in BALB/c mice at day 4 following CD8 depletion using CD8-specific Abs (Supplemental Fig. 4) . These data establish that iNKT cells contribute significantly, and nonredundantly, to early or innate defense against MCMV in BALB/c mice. 
Discussion
The importance of NK cells for innate immune responses to viral infections is well established; although iNKT cells also can be activated after exposure to viruses, in the absence of synthetic glycolipid Ag activation, there are relatively few examples in which these responses are protective. However, consistent with an important antiviral role for iNKT cells is the uncontrolled infection in response to the varicella-zoster vaccine in rare individuals lacking iNKT cells or CD1d and the finding that several viruses downregulate CD1d expression, suggesting evolutionary pressure for an immune-evasion mechanism targeting iNKT cells (36) (37) (38) (39) (40) (41) (42) . In this study, we show that NK cells and iNKT cells exhibit cytokineinduced activation in response to infection with MCMV, but that their cytokine requirements for activation differ, and that both cell types contribute to host protection. These data definitively show that iNKT and NK cells are differentially activated in the context of pathogen infection, perhaps in response to distinct APC subsets or other influences, and indicate they may play distinct roles in the control of infection.
iNKT cells express an invariant TCR that recognizes glycolipids, raising the issue as to how they participate in the immune response to viruses. However, several additional modes of activation allow iNKT cells to be activated by microbes in the absence of a microbial glycolipid presented by CD1d. First, activation can result from the presentation of self-glycolipid Ags by CD1d. The relevant self-Ags may include phospholipids and various types of glycosphingolipids (43) , but this response also requires IL-12 production by activated APCs. iNKT cells activated in this way predominantly produce IFN-g, in contrast to the diverse Th1 and Th2 cytokines that are elicited by strong glycolipid agonists for the TCR (e.g., aGalCer) (6, 26) . An exception to the requirement for IL-12 is one study (8) in which APCs were activated with CpG ODN; in this case, IFN-I was required as the cofactor for iNKT cell activation mediated by self-Ag.
Second, an additional pathway for iNKT cell activation is purely cytokine driven and does not require concomitant TCR engagement with any Ag presented by CD1d. In studying MCMV infection, we showed that activation by TLR9-mediated signaling leads to IL-12 release by APCs, resulting in iNKT cell production of IFN-g by ∼36 h postinfection. CD1d expression was not required, and IL-18 had a minimal role (3). Wesley et al. (10) reported similar results, but they observed a contribution of IFN-I for optimal iNKT cell activation during MCMV infection. In addition, we saw previously that iNKT cells increase expression of the activation marker CD69 as early as 12 h after MCMV infection, which is strictly dependent upon IFN-I produced by MCMV-infected splenic stromal cells (44) . However, the activated iNKT cells do not produce IFN-g at this early time, at least as assessed by intracellular cytokine staining directly ex vivo, although it remains to be determined whether lower amounts of IFN-g are produced or whether other effector functions are acquired. Interestingly, this "initial" IFN-I produced by stromal cells at 8-12 h of MCMV infection is sufficient to promote IFN-g production by some NK cells (44) , consistent with our results that IFN-b alone can induce IFN-g production by purified NK cells but not iNKT cells (Fig. 4) . The engagement of activating NK receptors, such as NK1.1, CD94/NKG2C, or NKG2D, provides a third, TCR-independent pathway for iNKT cell activation that is illustrative of their innate-or NK cell-like function (45) (46) (47) . However, because productive MCMV infection inhibits cell surface expression of ligands for activating NK receptors (48, 49) , it is likely that this mechanism of iNKT cell activation would be muted or absent when directly encountering virus-infected cells.
Although the critical importance of IL-12 for iNKT cell activation has been established, in this study we characterized, in detail, the cytokine-activation requirements for iNKT cells compared with NK cells. Interestingly, IL-12 alone did not induce iNKT cells to produce IFN-g in vitro. This is in agreement with our earlier findings that both IL-12 and IL-18 were required for iNKT cell stimulation in response to LPS in vitro or in vivo (9) . Furthermore, activation-induced arrest of iNKT cells in liver sinusoids was most evident when IL-12 and IL-18 were injected together (50) . In contrast, our earlier studies (3) of the response to MCMV demonstrated the importance of IL-12, but the absence of IL-18 had only a marginal effect. In this study, we showed that either IL-18 or IFN-I can synergize with IL-12 to activate iNKT cells in vitro. Therefore, in the context of MCMV infection, when high levels of IFN-I are produced, it is likely that IL-18 is largely redundant for iNKT cell activation.
We also now show that the cytokine requirements for NK cell stimulation in vitro to produce IFN-g are different, and generally less stringent, than are those for iNKT cells. This is most noticeable in the ability of NK cells to respond to single cytokines when added at higher concentrations, as well as their responses to combinations of either IL-18 + IFN-b or IL-12 + IFN-b. The only exception to this trend was that iNKT cells were more responsive to IL-18 in the presence of low IL-12 levels. The differential cytokine sensitivity of these two cell types correlated with the expression of cytokine receptors, suggesting that this could be a contributing factor. Furthermore, our in vivo data are generally consistent with the in vitro results. iNKT cells were unable to produce IFN-g in IL-12p40 2/2 mice, whereas NK cells remained partially responsive, presumably as the result of suboptimal activation by IL-18 and IFN-Ι. Somewhat surprisingly, however, production of IFN-g by NK cells in vivo was found to be highly dependent on IL-18 in the spleen. Based on our in vitro experiments, we would not have predicted this result, because other cytokines from innate cells were present at the time NK cells were analyzed. However, this finding is consistent with previous work showing that IL-18 is required for NK cell production of IFN-g in the spleen and for expansion of Ly49H + NK cells in vivo, as well as for IFN-g production by NK cells cocultured with MCMVinfected GM-CSF-derived BMDCs (29, 51, 52) . It should be noted that, although the in vitro work defines the capacity/ potential for NK or iNKT cells to respond to minimal cytokine concentrations, negative regulatory influences would be diminished in this set-up. For example, when cytokines are added to purified NK cells, the influence of cell surface molecules expressed by APCs acting on NK cell inhibitory receptors will be minimized. Furthermore, local cytokine concentrations may not reflect serum concentrations, and the existence of such local effects is supported by the organ-specific requirement for IL-18 for MCMV-mediated NK cell activation in the spleen but not the liver (29) .
Using two common methods for generating DC populations in vitro, we found that GM-CSF-derived BMDCs were capable of activating NK cells, but not iNKT cells, when infected with MCMV. The defining difference was not in the efficiency of the infection or in their ability to generally detect virus and subsequently produce cytokines. Instead, the defect was in the absence of IL-12 in the supernatant following MCMV infection. We do not know why GM-CSF-derived BMDCs do not produce IL-12 after MCMV infection, because they are competent to do so after exposure to CpG ODN. Regardless, as microbes evolve they are able to evade detection in numerous ways, including the blocking of production of critical cytokines from innate cells, and our results are consistent with previous work showing that productive infection of GM-CSF-derived BMDCs with MCMV inhibits their ability to produce IL-12 in response to secondary TLR activation (53) . The results from microarray analysis of gene expression suggest that GM-CSF-derived BMDCs are likely most similar to inflammatory monocytes (54) . However, the phenotype of DC subsets changes rapidly postinfection, and it is uncertain whether there is a DC population in vivo after MCMV infection that truly corresponds to GM-CSF-derived BMDCs. Nevertheless, it is certain from many studies that the cytokines produced by innate cells following infection will depend on the infecting agent and the cell subset that is activated. Therefore, extrapolating the MCMV results to other infections, it seems reasonable to propose that circumstances exist where the balance of activated APC types and cytokines produced could favor the preferential activation of NK or iNKT cells. There are only a few examples where iNKT cells were shown to affect viral clearance in the absence of pharmacologic activation by glycolipid Ag (55); therefore, a key issue is whether iNKT cell responses are important for limiting MCMV. We observed that viral replication was elevated in BALB/c mice that lack iNKT cells, especially in the liver. Depletion of NK cells from Ja18 2/2 BALB/c mice led to a further increase in replication.
These data indicate that NK cell activation postinfection is not completely dependent on iNKT cells, although, in some cases, activation of iNKT cells can contribute to NK cell stimulation; furthermore, considering the effects of NK cell depletion in iNKT cell-deficient mice, NK cell contribution to viral clearance is quantitatively quite similar to iNKT cell-mediated control. Therefore, NK cells and iNKT cells each play unique roles in antiviral defense in mice. Importantly, previous work showed that B6 mice lacking iNKT cells do not show enhanced replication of MCMV, and we saw similar results in Ja18 2/2 mice generated in this strain (data not shown). This could be due to several factors, including the more robust, Ly49H-dependent NK cell response in B6 mice or perhaps the differential effector cytokine production by iNKT cells in BALB/c mice compared with B6 mice. Because human CMV infection impacts the NK cell repertoire differentially in people of varying genetic backgrounds, perhaps it is not surprising that iNKT cells show a differential importance in controlling MCMV replication in mouse strains, because this is certainly the case for MCMV and NK cells (56) . Interestingly, as noted above, a drastic reduction in the number of iNKT cells and decreased CD1d expression have been associated, in a few cases, with disseminated varicella infection following the administration of the vaccine strain (36, 37) . Therefore, we must consider the possibility that iNKT cell activity is particularly important in humans for control of infections by Herpesviridae.
